Federal
Register Notices > Importers
>
Cerilliant Corporation
FR Doc E7-16862 [Federal Register: August 27, 2007 (Volume 72, Number 165)]
[Notices] [Page 49019] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27au07-69]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Prior to issuing a registration under 21
U.S.C. 952(a) (2) (B), and in
accordance with 21 CFR 1301.34
(a), this is notice that on July 20, 2007,
Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, TX 78664, made
application by renewal to the Drug Enforcement Administration (DEA) for
registration as an importer of the basic classes of controlled substances
listed in schedule I and II:
Drug
|
Schedule
|
Cathinone (1235)
|
I
|
Methcathinone (1237)
|
I
|
N-Ethylamphetamine (1475)
|
I
|
N,N-Dimethylamphetamine (1480)
|
I
|
Fenethylline (1503)
|
I
|
Gamma hydroxybutyric acid (2010)
|
I
|
Ibogaine (7260)
|
I
|
Lysergic acid diethylamide (7315)
|
I
|
Marihuana (7360)
|
I
|
Tetrahydrocannabinols (7370)
|
I
|
Mescaline (7381)
|
I
|
3,4,5-Trimethoxyamphetamine (7390)
|
I
|
4-Bromo-2,5-dimethoxyamphetamine (7391)
|
I
|
4-Bromo-2,5-dimethoxyphenethylamine (7392)
|
I
|
4-Methyl-2,5-dimethoxyamphetamine (7395)
|
I
|
2,5-Dimethoxyamphetamine (7396)
|
I
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
3,4-Methylenedioxy-N-ethylamphetamine (7404)
|
I
|
3,4-Methylenedioxymethamphetamine (7405)
|
I
|
4-Methoxyamphetamine (7411)
|
I
|
Alpha-methyltryptamine (7432)
|
I
|
Diethyltryptamine (7434)
|
I
|
Dimethyltryptamine (7435)
|
I
|
Psilocybin (7437)
|
I
|
Psilocyn (7438)
|
I
|
Phencyclidine (7471)
|
I
|
N-Benzylpiperazine (7493)
|
I
|
Etorphine (except HCI)(9056)
|
I
|
Heroin (9200)
|
I
|
Morphine-N-oxide (9307)
|
I
|
Normorphine (9313)
|
I
|
Pholcodine (9314)
|
I
|
Dextromoramide (9613)
|
I
|
Dipipanone (9622)
|
I
|
Trimeperidine (9646)
|
I
|
Amphetamine (1100)
|
II
|
Methamphetamine (1105)
|
II
|
Methylphenidate (1724)
|
II
|
Amobarbital (2125)
|
II
|
Pentobarbital (2270)
|
II
|
Secobarbital (2315)
|
II
|
Phenylacetone (8501)
|
II
|
Cocaine (9041)
|
II
|
Codeine (9050)
|
II
|
Dihydrocodeine (9120)
|
II
|
Oxycodone (9143)
|
II
|
Hydromorphone (9150)
|
II
|
Benzoylecgonine (9180)
|
II
|
Ethylmorphine (9190)
|
II
|
Meperidine (9230)
|
II
|
Methadone (9250)
|
II
|
Dextropropoxyphene, bulk (non-dosage forms)(9273)
|
II
|
Morphine (9300)
|
II
|
Thebaine (9333)
|
II
|
Levo-alphacetylmethadol (9648)
|
II
|
Oxymorphone (9652)
|
II
|
Poppy Straw Concentrate (9670)
|
II
|
The company plans to import small quantities of the listed controlled
substances for the manufacture of analytical reference standards.
Any bulk manufacturers who are presently, or are applying to be, registered
with DEA to manufacture such basic classes of controlled substances may file
comments or objections to the issuance of the proposed registration and may,
at the same time, file a written request for a hearing on such application
pursuant to 21 CFR 1301.43 and in such form as prescribed by
21 CFR
1316.47.
Any such comments or objections being sent via regular mail should be
addressed, in quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), Washington, DC.
20537; or any being sent via express mail should be sent to Drug Enforcement
Administration, Office of Diversion Control, Federal Register Representative (ODL),
2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no
later than September 26, 2007.
This procedure is to be conducted simultaneously with and independent of
the procedures described in 21 CFR 1301.34(b), (c), (d), (e) and (f). As noted
in a previous notice published in the Federal Register on September 23, 1975,
(40 FR 43745-46), all applicants for registration to import a basic class of
any controlled substances in Schedule I or II are and will continue to be
required to demonstrate to the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, that the requirements for
such registration pursuant to 21
U.S.C. 958(a); 21
U.S.C. 823(a); and 21 CFR
1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: August 16, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-16862 Filed 8-24-07; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|